Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects
Clinical trial NCT07024212 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07024212
- Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-22
- Primary completion
- 2026-06-18
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.